$320MSeries D, 10 September 2025
Oversubscribed Series D to fund clinical trials across five lead programs and its manufacturing engine.
- Amount
- $320M
- Stage
- Series D
- Announced
- 10 September 2025
- Lead
- Patient Square Capital
- Other investors
- Premji Invest, Peter Thiel, Narya Capital, The T1D Fund
- Use of funds
- Oversubscribed Series D to fund clinical trials across five lead programs and its manufacturing engine.
- Checked
- Announced by the company
- Sources
- Kriya Announces $320 Million Series D Financing to Advance - GlobeNewswire biospace.com
Kriya Announces $320 Million Series D Financing to Advance - GlobeNewswire GlobeNewswire